Differential gene expression in ACTH -secreting and non-functioning pituitary tumors

European Journal of Endocrinology

Volumn 157, Issue 6, 2007, Pages 717-724

  Tateno, Toru ^a   Izumiyama, Hajime ^a   Doi, Masaru ^a   Yoshimoto, Takanobu ^a   Shichiri, Masayoshi ^a   Inoshita, Naoko ^b   Oyama, Kenichi ^b   Yamada, Shozo ^b   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BRM RELATED PROTEIN 1; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GENE PRODUCT; GLUCOCORTICOID RECEPTOR ALPHA; HISTONE DEACETYLASE 2; LIPOCORTIN 1; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROPROTEIN CONVERTASE 3; SERINE PROTEINASE; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX19; UNCLASSIFIED DRUG; VASOPRESSIN V1 RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CRF RECEPTOR TYPE 1; GLUCOCORTICOID RECEPTOR; HOMEODOMAIN PROTEIN; NEUROD1 PROTEIN, HUMAN; TBX19 PROTEIN, HUMAN; VASOPRESSIN RECEPTOR;

ACTH SECRETING ADENOMA; ADULT; ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CORTICOTROPIN RELEASE; CUSHING DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; NONFUNCTIONING PITUITARY ADENOMA; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; STEADY STATE; BIOSYNTHESIS; FEEDBACK SYSTEM; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ACTH-SECRETING PITUITARY ADENOMA; ADRENOCORTICOTROPIC HORMONE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; FEEDBACK, BIOCHEMICAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; PRO-OPIOMELANOCORTIN; PROPROTEIN CONVERTASE 2; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-BOX DOMAIN PROTEINS;

EID: 38349061561     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0428     Document Type: Article

References (40)

1. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME & Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. American Journal of Pathology 1980 98 617-638.
2. Reincke M, Allolio B, Saeger W, Kaulen D & Winkelmann W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1987 65 1296-1300.
3. Morris D & Grossman A. The medical management of Cushing's syndrome. Annals of the New York Academy of Sciences 2002 970 119-133.
4. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS & Oyesiku NM. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. Journal of Clinical Endocrinology and Metabolism 2001 86 3097-3107.
5. Poulin G, Turgeon B & Drouin J. NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Molecular and Cellular Biology 1997 17 6673-6682.
6. Oyama K, Sanno N, Teramoto A & Osamura RY. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Modern Pathology 2001 14 892-899.
7. Herrmann BG, Labeit S, Poustka A, King TR & Lehrach H. Cloning of the T gene required in mesoderm formation in the mouse. Nature 1990 343 617-622.
8. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A & Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001 104 849-859.
9. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J & Brue T. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. Journal of Clinical Endocrinology and Metabolism 2003 88 3050-3056.
10. de Keyzer Y, Rene P, Beldjord C, Lenne F & Bertagna X. Overexpression. of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clinical Endocrinology 1998 49 475-482.
11. Raux MC, Binoux M, Luton JP, Gourmelen M & Girard F. Studies of ACTH secretion control in 116 cases of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1975 40 186-197.
12. Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Jr, Nicholson WE & Orth DN. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1996 81 2934-2941.
13. Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K Yoshinaga K et al. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders. Endocrine Journal 1993 40 597-606.
14. Thibonnier M, Preston JA, Dulin N, Wilkins PL, Berti-Mattera LN & Mattera R. The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology 1997 138 4109-4122.
15. Takumi I, Steiner DF, Sanno N, Teramoto A & Osamura RY. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy and laser scanning microscopy. Modern Pathology 1998 11 232-238.
16. Scopsi L, Gullo M, Rilke F, Martin S & Steiner DF. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation, Journal of Clinical Endocrinology and Metabolism 1995 80 294-301.
17. Jin L, Zhang S, Bayliss J, Scheithauer B, Qian X, Kobayashi I, Stridsberg M & Lloyd RV. Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies. Endocrine Pathology 2003 14 37-48.
18. Lloyd RV, Jin L, Qian X, Scheithauer BW, Young WF Jr & Davis DH. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. American Journal of Pathology 1995 146 1188-1198.
19. Ohta S, Nishizawa S, Oki Y, Yokoyama T & Namba H. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I - immunohistochemical study Pituitary 2002 5 221-223.
20. Matsuno A, Okazaki R, Oki Y & Nagashima T. Secretion of high-molecular-weight adrenocorticotropic hormone from a pituitary adenoma in a patient without Cushing stigmata. Case report. Journal of Neurosurgery 2004 101 874-877.
21. Iino K, Oki Y, Matsushita F, Yamashita M, Hayashi C, Miura K, Nishizawa S & Nakamura H. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease. Pituitary 2007 10 35-45.
22. Hirata Y, Yamamoto H, Matsukura S & Imura H. In vitro release and biosynthesis of tumor ACTH in ectopic ACTH producing tumors. Journal of Clinical Endocrinology and Metabolism 1975 41 106-114.
23. Gewirtz G, Schneider B, Krieger DT & Yalow RS. Big ACTH: conversion to biologically active ACTH by trypsin. Journal of Clinical Endocrinology and Metabolism 1974 38 227-230.
24. Ratter SJ, Gillies G, Hope J, Hale AC, Grossman A, Gaillard R, Cook D, Edwards CR & Rees LH. Pro-opiocortin related peptides in human pituitary and ectopic ACTH secreting tumours. Clinical Endocrinology 1983 18 211-218.
25. Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB & Stewart PM. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. Journal of Clinical Endocrinology and Metabolism 2001 86 2728-2733.
26. Parks LL, Turney MK, Gaitan D & Kovacs WJ. Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer. Journal of Steroid Biochemistry and Molecular Biology 1998 67 341-346.
27. Huizenga NA, de Lange P, Koper JW, Clayton RN, Farrell WE, van der Lely AJ, Brinkmann AO, de Jong FH & Lamberts SW. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. Journal of Clinical Endocrinology and Metabolism 1998 83 917-921.
28. Mu YM, Takayanagi R, Imasaki K, Ohe K, Ikuyama S, Yanase T & Nawata H. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test. Clinical Endocrinology 1998 49 301-306.
29. Antonini SR, Latronico AC, Elias LL, Cukiert A, Machado HR, Liberman B, Mendonca BB, Moreira AC & Castro M. Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours. Clinical Endocrinology 2002 57 657-662.
30. Tierney T, Christian HC, Morris JF, Solito E & Buckingham JC. Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. Journal of Neuroendocrinology 2003 15 1134-1143.
31. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ & Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 2003 144 1164-1174.
32. Turner BM. Histone acetylation and control of gene expression. Journal of Cell Science 1991 99 13-20.
33. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Current Opinion in Genetics and Development 1999 9 40-48.
34. Ito K, Barnes PJ & Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Molecular and Cellular Biology 2000 20 6891-6903.
35. Vradii D, Wagner S, Doan DN, Nickerson JA, Montecino M, Lian JB, Stein JL, van Wijnen AJ, Imbalzano AN & Stein GS. Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes. Journal of Cellular Physiology 2006 206 112-118.
36. Fryer CJ & Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998 393 88-91.
37. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, Meij B & Drouin J. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes and Development 2006 20 2871-2886.
38. Aguado F, Majo G, Ruiz-Montasell B, Canals JM, Casanova A, Marsal j & Blasi J. Expression of synaptosomal-associated protein SNAP-25 in endocrine anterior pituitary cells. European Journal of Cell Biology 1996 69 351-359.
39. Majo G, Ferrer I, Marsal J, Blasi J & Aguado F. Immunocytochemical analysis of the synaptic proteins SNAP-25 and Rab3A in human pituitary adenomas. Overexpression of SNAP-25 in the mammmosomatotroph lineages. Journal of Pathology 1997 183 440-446.
40. Nakamura N, Fukuda H, Kato A & Hirose S. MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking. Molecular Biology of the Cell 2005 16 1696-1710.